LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Coating of "Self” Peptides Protects Nanoparticles from Macrophage Destruction

By LabMedica International staff writers
Posted on 05 Mar 2013
Image: Diagram of Macrophage Interaction: Macrophages are immune cell “border guards” that have evolved to eat all sorts of foreign microbes, but they also eat many particles that are intended for therapeutics and imaging. A “Minimal peptide ‘Passport’” attached to the particles provides recognition signals so that the particles are not eaten, thus improving delivery to diseased cells in the body (Photo courtesy of Mary Leonard, Biomedical Art & Design, University of Pennsylvania).
Image: Diagram of Macrophage Interaction: Macrophages are immune cell “border guards” that have evolved to eat all sorts of foreign microbes, but they also eat many particles that are intended for therapeutics and imaging. A “Minimal peptide ‘Passport’” attached to the particles provides recognition signals so that the particles are not eaten, thus improving delivery to diseased cells in the body (Photo courtesy of Mary Leonard, Biomedical Art & Design, University of Pennsylvania).
Nanoparticles coated with peptides derived from the human protein CD47 were protected from uptake and destruction by macrophages in a genetically engineered mouse model system.

The membrane protein CD47 is reportedly a "marker of self" in mice that impedes phagocytosis of “self” molecules by signaling through the phagocyte receptor CD172a. CD47, which is found on almost all mammalian cell membranes, binds to the SIRPa macrophage receptor in humans.

Investigators at the University of Pennsylvania (Philadelphia, USA) used computers to design the smallest peptides from human CD47 (hCD47) that could perform the same function. They then synthesized these peptides and attached them to virus-size particles for intravenous injection into mice that had been genetically engineered to express a CD172a variant compatible with hCD47.

Results published in the February 22, 2013, issue of the journal Science revealed that the coating of “self” peptides delayed macrophage-mediated clearance of the nanoparticles, which promoted persistent circulation that enhanced dye and drug delivery to tumors.

"There may be other molecules that help quell the macrophage response," said senior author Dr. Dennis Discher, professor of chemical and biomolecular engineering at the University of Pennsylvania, "but human CD47 is clearly one that says, "Do not eat me. It can be made cleanly in a machine and easily modified during synthesis in order to attach to all sorts of implanted and injected things, with the goal of fooling the body into accepting these things as self."

Related Links:

University of Pennsylvania


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Urine Chemistry Control
Dropper Urine Chemistry Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more